AMF Tjanstepension AB Grows Holdings in UnitedHealth Group Incorporated $UNH

AMF Tjanstepension AB increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 30.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 309,549 shares of the healthcare conglomerate’s stock after purchasing an additional 71,585 shares during the quarter. AMF Tjanstepension AB’s holdings in UnitedHealth Group were worth $96,629,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC boosted its holdings in UnitedHealth Group by 164.9% during the second quarter. Future Financial Wealth Managment LLC now owns 1,486 shares of the healthcare conglomerate’s stock worth $464,000 after purchasing an additional 925 shares during the last quarter. Hennessy Advisors Inc. purchased a new position in UnitedHealth Group during the second quarter worth about $109,000. Ameriflex Group Inc. boosted its stake in UnitedHealth Group by 5.0% in the second quarter. Ameriflex Group Inc. now owns 1,938 shares of the healthcare conglomerate’s stock valued at $587,000 after acquiring an additional 92 shares during the last quarter. ZWJ Investment Counsel Inc. boosted its stake in UnitedHealth Group by 1.8% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,270 shares of the healthcare conglomerate’s stock valued at $1,020,000 after acquiring an additional 59 shares during the last quarter. Finally, Successful Portfolios LLC boosted its stake in UnitedHealth Group by 19.7% in the second quarter. Successful Portfolios LLC now owns 1,311 shares of the healthcare conglomerate’s stock valued at $409,000 after acquiring an additional 216 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Saturday, September 27th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Royal Bank Of Canada dropped their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $358.95.

Read Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $360.17 on Friday. The firm’s 50 day simple moving average is $307.84 and its 200 day simple moving average is $355.58. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $326.20 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% on a year-over-year basis. During the same period last year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.